MicroRNAs in normal and malignant hematopoiesis

Current Opinion in Hematology

Volumn 15, Issue 4, 2008, Pages 352-358

  Garzon, Ramiro ^a   Croce, Carlo M ^b  

^a Division of Hematology and Oncology   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Hematopoiesis; Leukemias; Lymphomas; MicroRNAs; Noncoding RNAs

Indexed keywords

MICRORNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; ERYTHROCYTE; GENE CONTROL; GENE OVEREXPRESSION; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNITY; LEUKEMIA; LEUKEMOGENESIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MEGAKARYOCYTE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; BLOOD DISEASE; GENETICS; PHYSIOLOGY;

ANIMALS; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HUMANS; LEUKEMIA; LYMPHOMA; MICRORNAS;

EID: 47149109822     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328303e15d     Document Type: Review

References (51)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
2. Kato M, Slack FJ. MicroRNAs: small molecules with big roles: C. elegans to human cancer. Biol Cell 2008; 100:71-81.
3. Felli N, Fontana L, Pelosi L, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102:18081-18086.
4. Dore L, Amigo JD, Dos Santos CO, et al. A GATA-1 regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 2008; 105:3333-3338.
5. Fazi F, Rosa A, Fatica A, et al.A minicircuitry comprised of microRNA-223and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005; 123:819-831.
6. Fontana L, Ballarino M, Sorrentino A, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9:775-787.
7. Calin GA, Dumitru C, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sc U S A 2002; 99:15524-15529.
8. Pekarsky Y, Santanam U,CimminoA, et al. Tcl1 expression in CLL is regulated by miR-29 and miR-181. Cancer Res 2006; 66:11590-11593.
9. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-838.
10. Mi S, Lu J, Sun M, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007; 104:19971-19976.
11. Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008; 111: 3183-3189.
12. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008; 105:3945-3950.
13. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-86.
14. Neilson JR, Zheng GXY, Burge CB, Sharp PA. Dynamic regulation of microRNAs expression in ordered stages of cellular development. Genes Dev 2007; 21:578-589.
15. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131:146-159.
16. Zhou B, Wang S, Mayr C, et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104:7080-7085.
17. Ventura A, Young AG, Winslow MA, et al. Targeted deletion reveals essential and overlapping functions of the miR-17-92 family of miRNA clusters. Cell 2008; 132:875-886.
18. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129:147-161.
19. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sc U S A 2006; 103:5078-5083.
20. Bruchova H, Yoon D, Agarwal AM, et al. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007; 35: 1657-1667.
21. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007; 26:4148-4157.
22. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of micro- RNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205:585-594.
23. Georgantas RW, Hildreth R, Morisot S, et al. CD34+ hematopoietic stemprogenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007; 104:2750-2755.
24. Monticelli S, Ansel MK, Xiao C, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005; 6:R71.
25. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316:604-608.
26. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608-611.
27. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of proliferation and granulocyte function by miR-223. Nature 2008; 451:1125-1129.
28. Fukao T, Yoko F, Kotaro K, et al. An evolutionary conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007; 129:617-631.
29. Croce C. Oncogenes and cancer. N Engl J Med 2008; 358:502-511.
30. Bullrich F, Fujii H, Calin GA, et al. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1 ,an alternative splice variant of the LEU2 gene. Cancer Res 2001; 61:6640-6648.
31. Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353:1793-1801.
32. Scaglione BJ, Salerno E, Raveche E, et al. Murine models of chronic lymphocytic leukaemia: role of microRNA-1 6 in the New Zealand black mouse model. Br J Haematol 2007; 139:645-657.
33. Raveche ES, Salerno E, Scaglione BJ, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109:5079-5086.
34. Kitada S, Andersen J, Akar S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91:3379-3389.
35. Adachi M, Tefferi A, Greipp PR, et al. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 1990; 171:559-564.
36. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sc U S A 2005; 102:13944-13949.
37. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BICRNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102:3627-3632.
38. Kluiver J, PoppemaS, de Jong D, et al. BICand miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207:243-249.
39. Metzler M, Wilda M, Busch K, et al. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39:167-169.
40. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103:7024-7029.
41. He L, Thomsom M, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-833.
42. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64:3087-3095.
43. Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Inmunol 2008; 9:405-414. In this paper, the authors described important results that add to our understanding of this cluster function in normal and malignant hematopoiesis.
44. Mott JL, Kobayashi S, Bronk SF, Gores GJ. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26:6133-6140.
45. Pekarsky Y, Koval A, Hallas C, et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A 2000; 97:3028-3033.
46. Herling M, Patel KA, Khalili J, et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 2006; 20:280-285.
47. Yan XJ, Albesiano E, Zanesi N, et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2006; 103:11713-11718.
48. Burnett AK. Current controversies: which patients with acute myeloid leukemia should receive bone marrow transplantation? An adult theater's view. Br J Haematol 2002; 118:357-364.
49. Venturini L, Battmer K, Castoldi M, et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007; 109:4399-4405.
50. O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-843.
51. Leone G, DeGregori J, Sears R, et al. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387:422-426.